Skip to main content
Clinical Trials/ACTRN12609000104257
ACTRN12609000104257
Recruiting
Phase 2

A randomised controlled trial to study the effectiveness of potent bisphosphonate (Zoledronic Acid) therapy in patients with early osteonecrosis of the hip.

niversity of Sydney/ Northern Clinical School0 sites120 target enrollmentFebruary 13, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
osteonecrosis of the hip
Sponsor
niversity of Sydney/ Northern Clinical School
Enrollment
120
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Sydney/ Northern Clinical School

Eligibility Criteria

Inclusion Criteria

  • symptoms of pain and disability in at least one hip joint and/or positive MRI findings stage I or II on the ARCO classification

Exclusion Criteria

  • Previous hip joint surgery on the affected hip and/or severe pain and disability at rest if treating clinician has recommended surgery and/or Radiographic or MRI findings suggestive for stage III and IV on the ARCO classification

Outcomes

Primary Outcomes

Not specified

Similar Trials